UW-Milwaukee chemistry professor, students help fill gaps in state s biohealth talent pipeline biztimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztimes.com Daily Mail and Mail on Sunday newspapers.
Curie Therapeutics will be provided with priority access to NorthStar’s high purity non-carrier added (n.c.a.) Ac-225, which will be used to advance its multimodal pipeline of precision radiopharmaceuticals to address broad unmet needs in treatment of patients with solid tumors
NorthStar’s high purity non-carrier-added (n.c.a.) Ac-225 to be used in Convergent’s lead, dual-targeted radionuclide program for prostate cancer, CONV01-α
NorthStar Medical Radioisotopes and Convergent Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225) - read this article along with other careers information, tips and advice on BioSpace
NorthStar Medical: Radioisotopes and Convergent Therapeutics announce supply agreement for Therapeutic Radioisotope Actinium-225 (Ac-225) wisbusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wisbusiness.com Daily Mail and Mail on Sunday newspapers.